[
    {
        "file_name": "PREMIERBIOMEDICALINC_05_14_2020-EX-10.2-INTELLECTUALPROPERTYAGREEMENT.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "Licenses granted herein are solely for products in the form sold by the Licensee and are not to be construed either (i) as consent by the Marv to any act which may be performed by the Licensee, except to the extent impacted by a patent licensed herein to the Licensee, or (ii) to include licenses to contributorily infringe or induce infringement under U.S. law or a foreign equivalent thereof.",
                "changed_text": "Licenses granted herein are solely for products in the form sold by the Licensee and are not to be construed either (i) as consent by the Marv to any act which may be performed by the Licensee, except to the extent impacted by a patent licensed herein to the Licensee, or (ii) to include licenses to contributorily infringe or induce infringement under U.S. law or a foreign equivalent thereof, notwithstanding the doctrine of equivalents.",
                "explanation": "By adding \"notwithstanding the doctrine of equivalents,\" the agreement now conflicts with established patent law regarding infringement under the doctrine of equivalents.",
                "contradicted_law": "35 U.S. Code § 271 - Infringement of patent",
                "law_citation": "35 U.S.C. § 271",
                "law_url1": [
                    "https://www.law.cornell.edu/uscode/text/35/271"
                ],
                "law_url2": [
                    "https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title35-section271&edition=prelim"
                ],
                "law_explanation": "This modification attempts to waive the patent holder's right to pursue infringement claims based on the doctrine of equivalents, which is a legal principle allowing a patent to be infringed even if the infringing product or process does not literally meet the claim limitations but is substantially equivalent. This attempts to limit the scope of patent protection afforded by law.",
                "location": "2. LICENSING. (a) License - THI is granted the following rights to the Applications in Appendix A and the Licensed Products derived therefrom: Scope. 4."
            },
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "Each Party agrees to hold in confidence confidential information acquired in the course of this relationship with the other Parties and their associates. Each Party agrees to refrain from, either during period of this Agreement or at any other time thereafter, disclosing, using or disseminating such confidential information, for its or another's benefit, in any way acquired in the course of any association arising out of this Agreement.",
                "changed_text": "Each Party agrees to hold in confidence confidential information acquired in the course of this relationship with the other Parties and their associates. Each Party agrees to refrain from, either during period of this Agreement or at any other time thereafter, disclosing, using or disseminating such confidential information, for its or another's benefit, in any way acquired in the course of any association arising out of this Agreement, irrespective of whistleblower protections.",
                "explanation": "The phrase 'irrespective of whistleblower protections' creates a contradiction because it attempts to prevent parties from disclosing information even if they are protected under whistleblower laws.",
                "contradicted_law": "18 U.S. Code § 1833 - Protection of trade secrets",
                "law_citation": "18 U.S.C. § 1833(b)",
                "law_url1": [
                    "https://www.law.cornell.edu/uscode/text/18/1833"
                ],
                "law_url2": [
                    "https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title18-section1833&edition=prelim"
                ],
                "law_explanation": "This change attempts to restrict whistleblower protections, which are enshrined in federal law (specifically 18 U.S.C. § 1833(b) relating to trade secrets and whistleblower immunity). The modification purports to prevent disclosure of confidential information even when the disclosing party is legally protected as a whistleblower reporting potential illegal activity.",
                "location": "7. CONFIDENTIALITY."
            },
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "Venue for any action brought under this Agreement shall be in the appropriate court in Mercer County, Pennsylvania.",
                "changed_text": "Venue for any action brought under this Agreement shall be exclusively in the court of Premier Biomedical, Inc.'s choosing.",
                "explanation": "Changing the venue clause to 'Premier Biomedical, Inc.'s choosing' contradicts established legal principles regarding fair venue selection. This could conflict with laws that ensure a neutral and appropriate jurisdiction for legal disputes.",
                "contradicted_law": "28 U.S. Code § 1391 - Venue generally",
                "law_citation": "28 U.S.C. § 1391",
                "law_url1": [
                    "https://www.law.cornell.edu/uscode/text/28/1391"
                ],
                "law_url2": [
                    "https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title28-section1391&edition=prelim"
                ],
                "law_explanation": "The original clause specifies venue in Mercer County, Pennsylvania. The changed clause allows Premier Biomedical, Inc. to choose the venue, potentially violating 28 U.S.C. § 1391, which governs venue in federal courts. This statute ensures that venue is proper based on factors like the defendant's residence or where the cause of action arose, rather than solely at the discretion of one party.",
                "location": "8. VENUE."
            }
        ]
    }
]